RT Journal Article
SR Electronic
T1 The timing of COVID-19 transmission
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.04.20188516
DO 10.1101/2020.09.04.20188516
A1 Luca Ferretti
A1 Alice Ledda
A1 Chris Wymant
A1 Lele Zhao
A1 Virginia Ledda
A1 Lucie Abeler-Dörner
A1 Michelle Kendall
A1 Anel Nurtay
A1 Hao-Yuan Cheng
A1 Ta-Chou Ng
A1 Hsien-Ho Lin
A1 Rob Hinch
A1 Joanna Masel
A1 A. Marm Kilpatrick
A1 Christophe Fraser
YR 2020
UL http://medrxiv.org/content/early/2020/09/16/2020.09.04.20188516.abstract
AB The timing of SARS-CoV-2 transmission is a critical factor to understand the epidemic trajectory and the impact of isolation, contact tracing and other non-pharmaceutical interventions on the spread of COVID-19 epidemics. We examined the distribution of transmission events with respect to exposure and onset of symptoms. We show that for symptomatic individuals, the timing of transmission of SARS-CoV-2 is more strongly linked to the onset of clinical symptoms of COVID-19 than to the time since infection. We found that it was approximately centered and symmetric around the onset of symptoms, with three quarters of events occurring in the window from 2-3 days before to 2-3 days after. However, we caution against overinterpretation of the right tail of the distribution, due to its dependence on behavioural factors and interventions. We also found that the pre-symptomatic infectious period extended further back in time for individuals with longer incubation periods. This strongly suggests that information about when a case was infected should be collected where possible, in order to assess how far into the past their contacts should be traced. Overall, the fraction of transmission from strictly pre-symptomatic infections was high (41%; 95%CI 31-50%), which limits the efficacy of symptom-based interventions, and the large fraction of transmissions (35%; 95%CI 26-45%) that occur on the same day or the day after onset of symptoms underlines the critical importance of individuals distancing themselves from others as soon as they notice any symptoms, even if they are mild. Rapid or at-home testing and contextual risk information would greatly facilitate efficient early isolation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was funded by an award from the Li Ka Shing Foundation to CF. The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB needed.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll datasets used in this paper are published or publicly available.